DLBCL-话题@MedSci

#DLBCL#

51篇内容 | 2753人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1360487, encodeId=5d53136048ee5, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=【2018EHA抢先看】年龄或许不是问题！高龄DLBCL患者也可从蒽环类方案中获益, objectType=article, longId=139493, objectId=415913949326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=415913949326, replyNumber=0, likeNumber=66, createdTime=2018-06-01, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=415913949326, moduleTitle=【2018EHA抢先看】年龄或许不是问题！高龄DLBCL患者也可从蒽环类方案中获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=415913949326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360486, encodeId=1fe813604865a, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=Blood：对于限制期DLBCL患者，R-CHOP化疗联合放射治疗的效果并不优于单纯R-CHOP化疗。, objectType=article, longId=117566, objectId=76bc11e5667f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76bc11e5667f, replyNumber=0, likeNumber=88, createdTime=2017-10-27, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76bc11e5667f, moduleTitle=Blood：对于限制期DLBCL患者，R-CHOP化疗联合放射治疗的效果并不优于单纯R-CHOP化疗。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76bc11e5667f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360485, encodeId=475a13604852a, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=重复：J Clin Oncol：来那度胺用于DLBCL老年患者一线维持治疗结果喜人, objectType=article, longId=110434, objectId=236e110434c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=236e110434c4, replyNumber=0, likeNumber=88, createdTime=2017-08-23, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=236e110434c4, moduleTitle=重复：J Clin Oncol：来那度胺用于DLBCL老年患者一线维持治疗结果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=236e110434c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360484, encodeId=ea551360484be, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=Br J Haematol：现代治疗中DLBCL后原发恶性肿瘤的发病率, objectType=article, longId=105797, objectId=fc63105e9745, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc63105e9745, replyNumber=0, likeNumber=84, createdTime=2017-07-19, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc63105e9745, moduleTitle=Br J Haematol：现代治疗中DLBCL后原发恶性肿瘤的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc63105e9745)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360483, encodeId=8683136048357, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=JCO：来那度胺+R-CHOP维持治疗，老年DLBCL患者预后如何？, objectType=article, longId=100056, objectId=c37410005683, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c37410005683, replyNumber=0, likeNumber=0, createdTime=2017-05-30, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c37410005683, moduleTitle=JCO：来那度胺+R-CHOP维持治疗，老年DLBCL患者预后如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c37410005683)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360482, encodeId=3b2b13604826f, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=Blood:一项LYSA研究：利妥昔单抗暴露受基线代谢肿瘤体积影响并可预测DLBCL患者疗效, objectType=article, longId=90981, objectId=fe4c90981ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe4c90981ab, replyNumber=0, likeNumber=72, createdTime=2017-03-08, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe4c90981ab, moduleTitle=Blood:一项LYSA研究：利妥昔单抗暴露受基线代谢肿瘤体积影响并可预测DLBCL患者疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe4c90981ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360481, encodeId=f37b1360481e8, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=JCO：首次完全缓解后的DLBCL病人是否需要常规影像检查？, objectType=article, longId=57081, objectId=921b5e08167, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=921b5e08167, replyNumber=0, likeNumber=70, createdTime=2015-10-12, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=921b5e08167, moduleTitle=JCO：首次完全缓解后的DLBCL病人是否需要常规影像检查？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=921b5e08167)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360480, encodeId=0b6b136048092, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=J Clin Pathol：过氧化还原酶VI的高表达预示DLBCL的不良结局, objectType=article, longId=50467, objectId=9eb75046ed4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9eb75046ed4, replyNumber=0, likeNumber=59, createdTime=2015-05-10, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9eb75046ed4, moduleTitle=J Clin Pathol：过氧化还原酶VI的高表达预示DLBCL的不良结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9eb75046ed4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360479, encodeId=a1ce13604e96d, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=JCO：无症状弥漫性大B细胞淋巴瘤（ DLBCL ）影像监控获益小, objectType=article, longId=48969, objectId=a8984896926, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8984896926, replyNumber=0, likeNumber=64, createdTime=2015-04-05, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8984896926, moduleTitle=JCO：无症状弥漫性大B细胞淋巴瘤（ DLBCL ）影像监控获益小, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8984896926)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360478, encodeId=efd613604e87b, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=Hematol Oncol：EBV阳性DLBCL患者表达CD30提示预后不良, objectType=article, longId=21347, objectId=f5772134eb9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5772134eb9, replyNumber=0, likeNumber=60, createdTime=2013-07-15, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5772134eb9, moduleTitle=Hematol Oncol：EBV阳性DLBCL患者表达CD30提示预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5772134eb9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360477, encodeId=746413604e71f, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=ASCO 2013：黄河教授研究认为预防DLBCL乙肝再激活恩替卡韦疗效似更优, objectType=article, longId=19648, objectId=562019648ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=562019648ab, replyNumber=0, likeNumber=58, createdTime=2013-06-06, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=562019648ab, moduleTitle=ASCO 2013：黄河教授研究认为预防DLBCL乙肝再激活恩替卡韦疗效似更优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=562019648ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360476, encodeId=0f4313604e6b2, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=JCO：放射免疫结合移植方案治疗DLBCL复发患者无明显获益, objectType=article, longId=17413, objectId=dad31e41321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dad31e41321, replyNumber=0, likeNumber=57, createdTime=2013-04-17, rootId=0, userName=cathymary, userId=226a143, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dad31e41321, moduleTitle=JCO：放射免疫结合移植方案治疗DLBCL复发患者无明显获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dad31e41321)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

DLBCL

2020-05-29

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

【2018EHA抢先看】年龄或许不是问题！高龄DLBCL患者也可从蒽环类方案中获益

2018-06-01

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

Blood：对于限制期DLBCL患者，R-CHOP化疗联合放射治疗的效果并不优于单纯R-CHOP化疗。

2017-10-27

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

重复：J Clin Oncol：来那度胺用于DLBCL老年患者一线维持治疗结果喜人

2017-08-23

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

Br J Haematol：现代治疗中DLBCL后原发恶性肿瘤的发病率

2017-07-19

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

JCO：来那度胺+R-CHOP维持治疗，老年DLBCL患者预后如何？

2017-05-30

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

Blood:一项LYSA研究：利妥昔单抗暴露受基线代谢肿瘤体积影响并可预测DLBCL患者疗效

2017-03-08

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

JCO：首次完全缓解后的DLBCL病人是否需要常规影像检查？

2015-10-12

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

J Clin Pathol：过氧化还原酶VI的高表达预示DLBCL的不良结局

2015-05-10

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

JCO：无症状弥漫性大B细胞淋巴瘤（ DLBCL ）影像监控获益小

2015-04-05

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

Hematol Oncol：EBV阳性DLBCL患者表达CD30提示预后不良

2013-07-15

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

ASCO 2013：黄河教授研究认为预防DLBCL乙肝再激活恩替卡韦疗效似更优

2013-06-06

cathymary (审核中...)

前往app查看评论内容

#DLBCL#

JCO：放射免疫结合移植方案治疗DLBCL复发患者无明显获益

2013-04-17

科室
- - 订阅+
  - 更多科室
工具
服务